Brentuximab vedotin (Adcetris) improves survival among patients with anaplastic large cell lymphoma or CD30-expressing mycosis fungoides.
Breast Cancer
Latest News
Advertisement
CME Content
Advertisement
Ribociclib (Kisqali) combination therapy may improve survival among premenopausal breast cancer patients.
A comprehensive knowledge of the risk of breast cancer can lead to better screening.
Trastuzumab monotherapy was not linked to surgical complications among patients with breast cancer undergoing reconstruction after a mastectomy.
A byproduct of cholesterol metabolism may fuel the spread of solid tumors.
Exposure to many chemicals, including gasoline, can heighten the risk of developing breast cancer.
New discovery about EGFR signaling may prevent cancer cells from spreading.
The mechanisms of BRCA mutations are still largely unknown.
Mammography plays an important role in breast cancer detection.
Early detection is crucial for breast cancer survival.
Top news of the day from across the healthcare landscape.
Top news of the day from across the healthcare landscape.
Mastectomy rates increased after actress Angelia Jolie announced her procedure.
Mass spectrometry device rapidly identifies molecular profile of cancerous tissue.
Top news of the day from across the health care landscape.
Top news of the day from across the healthcare landscape.
Gadolinium-containing imaging agent could improve breast cancer survival.
Pertuzumab-based regimen shows promise treating adjuvant treatment of HER2-positive early breast cancer.
Genentech is seeking approval for Perjeta used in combination with trastuzumab and chemotherapy for adjuvant treatment of HER2-positive early breast cancer.
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
Abemaciclib treats adults with hormone receptor-positive, human epidemical growth factor receptor-negative advanced or metastatic breast cancer that progressed after endocrine therapy.
Verzenio can be administered as a stand-alone treatment to patients previously treated with endocrine therapy and chemotherapy.
Officials with the FDA have approved abemaciclib (Verzenio, Eli Lilly), for the treatment of adults with certain advanced or metastatic breast cancer.
Top news of the week from Specialty Pharmacy Times.
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Controversial 340B Rebate Pilot Program Is Moving Forward
2
Symbravo Offers Multi-Mechanistic Option for Patients With Unmet Migraine Needs
3
Researchers Identify Key Lipid Pathways That Influence Alzheimer’s Progression
4
Infants Have Higher Risk of Developing Asthma When Hospitalized With RSV
5
